Apollo Cancer Centre Leads the Way with India's First LungLife Screening Program to Combat Lung Cancer!
Chennai, December 3 2024: Apollo Cancer
Centres (ACCs), a leader in cutting-edge cancer care, has launched India's first LungLife Screening Program for early detection of lung cancer. This ground-breaking initiative aims to combat lung cancer, which accounts for 5.9% of all cancers and 8.1% of cancer-related deaths in India. Early detection aids in better treatment outcome and enhances the survival rate. (LINK)
GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer (IARC) show as lung cancer remains the leading cause of cancer death, with an estimated 1.8 million deaths (18%) in 2020.
The LungLife Screening Program aims at individuals who have the highest risk for lung cancer such as: (i) people between the age group of 50 and 80 years, (ii) asymptomatic (no signs or symptoms of lung cancer), (iii) individuals with a significant history of smoking and (iv) people with family history of lung cancers.
Early screening through low-dose computed tomography (LDCT) can aid in early detection and significantly improve survival rates. Yet approximately 80% of high risk individuals have never discussed screening with their healthcare providers. It is vital to enhance communication and awareness around lung cancer screening to enable early diagnosis and save lives, especially among high-risk population.
Mr Harshad, Director
Group Oncology & International, Apollo Hospitals said, "It is a privilege to introduce the Lung-Life Screening Program, a pioneering initiative that marks a significant milestone in Apollo Cancer Centre's journey of advancing oncology care in India. This program is a testament to our unwavering commitment to equipping individuals with the resources and knowledge to actively protect their health and embrace a life of possibilities. Through this initiative, Apollo Cancer Centres remains steadfast in its mission to elevate the standards of cancer care and awareness in India, inspiring nationwide action and collaboration in the fight against lung cancer."
Dr Sridhar Ravichandran, Consultant Pulmonologist, Apollo Proton Cancer Centre, said, "Lung cancer remains one of the deadliest
cancers globally, but early detection notably enhances survival chances. Through our Lung- Life Screening Program, we aim to identify high- risk individuals early, using advanced low-dose CT technology, which minimizes radiation exposure precision. while maximizing diagnostic This program is particularly impactful for individuals with a history of smoking, passive smoking exposure, or a family history of lung cancer. By detecting lung cancer at a treatable stage, we empower patients with better treatment outcomes and build renewed hope for a healthier future." a
Dr PB. Vandana, Pulmonary Medicine - Apollo Specialty Hospitals, Vanagaram, said, "The introduction of Apollo Cancer Centre's Lung-Life Screening Program marks a pivotal step in addressing the alarming rise of lung cancer in India. With this comprehensive screening program, we focus on early-stage detection, where the chances of effective treatment and recovery are exponentially higher. The program leverages state-of-the-art low-dose CT scans, ensuring accurate diagnoses while prioritizing patient safety. Together, we are not just treating cancer but transforming lives through timely interventions and holistic care tailored to individual needs."
Dr Jebin Roger S, Consultant Pulmonologist, Apollo Cancer Centre, Teynampet, said, "Lung
cancer is a cilent threat often detected only
